IRIDEX (NASDAQ:IRIX) Posts Quarterly Earnings Results

IRIDEX (NASDAQ:IRIX) released its earnings results on Thursday. The medical equipment provider reported ($0.05) EPS for the quarter, Zacks reports. IRIDEX had a negative net margin of 22.79% and a negative return on equity of 192.95%.

IRIDEX Stock Down 1.8 %

Shares of NASDAQ IRIX traded down $0.02 on Thursday, reaching $0.88. 104,431 shares of the company’s stock traded hands, compared to its average volume of 39,800. The business’s 50 day simple moving average is $1.41 and its two-hundred day simple moving average is $1.60. IRIDEX has a 12 month low of $0.78 and a 12 month high of $3.65. The company has a market cap of $14.69 million, a price-to-earnings ratio of -1.32 and a beta of 0.94. The company has a quick ratio of 0.85, a current ratio of 1.54 and a debt-to-equity ratio of 0.55.

Analyst Ratings Changes

Separately, StockNews.com began coverage on IRIDEX in a research report on Tuesday. They set a “hold” rating for the company.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.